drugset
drugset / Trial / NCT01396668

Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic Cancer

NCT01396668 ↗

Phase 2 Completed 35 enrolled Seoul National University Hospital
NaSingle-groupOpen-labelTreatment

Summary

This is a phase Ⅱ trial of fixed dose rate gemcitabine and cisplatin chemotherapy followed by chemoradiation with capecitabine in patients with locally advanced pancreatic cancer.

Timeline

Start
2004-12
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Capecitabine Small molecule 650 mg/m2 —
Subject Cisplatin Other / unclassified 60 mg/m2 —
Subject Gemcitabine Small molecule 1000 mg/m2 —

Indications

malignant pancreatic neoplasm